Jonathan Guarino
Financieel Directeur/CFO bij SOLIGENIX, INC.
Vermogen: 313 $ op 30-04-2024
Actieve functies van Jonathan Guarino
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SOLIGENIX, INC. | Financieel Directeur/CFO | 11-09-2019 | - |
| Bedrijfssecretaris | - | - | |
| Corporate Officer/Principal | 11-09-2019 | - |
Loopbaan van Jonathan Guarino
Eerdere bekende functies van Jonathan Guarino
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01-09-2016 | 01-07-2019 |
| Suite-K Value Added Services LLC | Comptroller/Controller/Auditor | 01-08-2015 | 01-09-2016 |
| COVANCE INC. | Comptroller/Controller/Auditor | 01-06-2014 | 01-05-2015 |
Opleiding van Jonathan Guarino
| Montclair State University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Comptroller/Controller/Auditor | 3 |
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
| Suite-K Value Added Services LLC |
- Beurs
- Insiders
- Jonathan Guarino
- Ervaring
